Seven Seeger Weiss Partners Named to 2025 Lawdragon 500 Leading Litigators in America List

Seeger Weiss is proud to announce that seven partners — Chris Seeger, Stephen Weiss, David Buchanan, Shauna Itri, Parvin Aminolroaya, Matt Pawa, and Jennifer Scullion — have been named to the 2025 Lawdragon 500 Leading Litigators in America list. This prestigious guide, first published in 2007, seeks to highlight 500 of the most distinguished litigators […]

September 9, 2024

Seeger Weiss is proud to announce that seven partners — Chris Seeger, Stephen Weiss, David Buchanan, Shauna Itri, Parvin Aminolroaya, Matt Pawa, and Jennifer Scullion — have been named to the 2025 Lawdragon 500 Leading Litigators in America list. This prestigious guide, first published in 2007, seeks to highlight 500 of the most distinguished litigators in the United States, specializing in areas such as antitrust, intellectual property, white collar crime, and complex civil litigation. According to Lawdragon, “These lawyers win hundreds of millions, billions even. They win freedom or lose it for someone. They have the abilities to change businesses and entire industries.”

Chris Seeger, co-founding partner of Seeger Weiss, has consistently appeared on several Lawdragon guides and was named a “Lawdragon Legend” in 2016.  Throughout his career, Chris has led some of the most complex, groundbreaking, and high-profile litigations that have shaped the world for the better. Within this last year, Chris achieved remarkable success, securing major settlements for injured plaintiffs in complex cases. As co-lead counsel, he negotiated a settlement exceeding $6 billion in the 3M Combat Arms Earplug Litigation. Additionally, he secured over $533.5 million in the Proton Pump Inhibitor Litigation and an uncapped $600 million agreement to resolve economic loss claims in the Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Litigation.

Stephen Weiss, co-founding partner of Seeger Weiss, leads the firm’s qui tam/whistleblower practice, focusing on healthcare and tax fraud under federal and state False Claims Acts. He has litigated against CareCore National, Warner Chilcott, and Life Spine, Inc., and secured the first settlement under New York’s 2010 tax whistleblower amendments. In March 2023, he helped achieve a $10 million settlement with Stimwave for False Claims Act violations. His practice also includes high-profile multidistrict litigation, arbitrations, and private business disputes across various sectors such as consumer products, insurance, agriculture, environment, securities, property rights, and employment litigation.

Senior partner David Buchanan represents both individual and corporate plaintiffs in state and federal courts. He was recently appointed co-lead counsel for the Self-Funded Payer Track in the Insulin Pricing Litigation. Dave has also played key roles on the Plaintiffs’ Steering Committee in the 3M Combat Arms Earplug Litigation, the largest mass tort in U.S. history, and the Plaintiffs’ Executive Committee in the NFL Concussion Litigation. Additionally, he co-chaired discovery and served as lead counsel in several bellwether trials in the Vioxx Litigation.

With over a decade of experience leading complex litigation, including securities and consumer matters, Shauna Itri has helped secure major settlements including a $42.6 million settlement with Renaissance RX (RenRX) and a $13 million settlement with medical device company Covidien. Shauna also played an instrumental role in the Philips CPAP litigation and resulting settlements. Most recently, Shauna was appointed to the Plaintiffs’ Executive Committee in the AT&T Data Breach Multidistrict Litigation.

Partner Parvin Aminolroaya joined Seeger Weiss in 2008 and is a skilled litigator, helping lead some of the most significant and complex mass tort and class action cases. Notably, she served as co-lead counsel in the Elmiron (Pentosan Polysulfate Sodium) Litigation which brought compensation and justice to women for their injuries using the product. Parvin was recently appointed to co-lead counsel in the Glucagon-like Peptide-1 (GLP-1) Receptor Agonists Litigation, where patients are filing lawsuits against pharmaceutical companies Novo Nordisk and Eli Lilly. These lawsuits involve claims that popular GLP-1 receptor agonist medications, such as Ozempic and Mounjaro, caused serious medical complications without adequate warning.

Matt Pawa, a trailblazer in environmental litigation for over 25 years, has been instrumental in high-profile cases. He currently represents Vermont and Maine in lawsuits against 3M and DuPont for polluting the states’ land and waters with PFAS “forever chemicals.” Recently, Matt secured settlements of $25 million for New Hampshire and $80 million for Virginia in cases against Monsanto for PCB contamination of state waters.

With over 20 years of experience, Jennifer Scullion has led complex litigations, arbitrations, and appeals for U.S. and multinational clients across various areas, including antitrust, consumer fraud, communications, civil rights, and international bondholder disputes. Currently, she is a member of the Plaintiffs’ Executive Committee, Settlement Committee, Manufacturers’ Committee, and Law & Briefing Committee in the National Prescription Opiate Litigation. This multidistrict litigation prosecutes RICO, public nuisance, and related claims on behalf of local governments. Additionally, Jen serves as co-lead counsel for the negotiation class.

Lawdragon’s selection methodology can be found here.

No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey.

Prior results do not guarantee or predict a similar outcome in any future matter.

Related News

October 3, 2024
Seeger Weiss Partner Jennifer Scullion Appointed Plaintiff’s Steering Committee Co-Chair in Change Healthcare Data Breach Litigation

RIDGEFIELD PARK, NJ – Seeger Weiss partner Jennifer Scullion has been appointed as co-chair of the Plaintiff’s Steering Committee for the Provider Track by the Honorable Judge Donovan W. Frank in the Change Healthcare, Inc. Customer Data Security Breach Litigation. The multidistrict litigation centralized in the District of Minnesota consolidates nearly 50 class action lawsuits […]

Read More
September 17, 2024
Seeger Weiss Named Regional Powerhouse by Law360

Seeger Weiss has been honored with the 2024 Regional Powerhouse Award from Law360, recognizing the firm’s pivotal role in shaping the legal landscape in New Jersey and beyond. Known for its leadership in complex litigation and significant contributions to mass torts, environmental law, product liability, and eDiscovery, Seeger Weiss remains dedicated to providing our high […]

Read More
September 6, 2024
Seeger Weiss Partner Parvin Aminolroaya Featured on CBS News Discussing Ozempic Litigation

Seeger Weiss partner Parvin Aminolroaya recently appeared on CBS News to discuss ongoing litigation against pharmaceutical companies Novo Nordisk and Eli Lilly over their popular GLP-1 receptor agonist medications such as Ozempic, Wegovy, Mounjaro, and Zepbound. Our firm represents patients across the country who allege they suffered serious medical complications while taking these drugs and […]

Read More